R B Weiss

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

John C. Byrd, R B Weiss, D C Arthur et al. · Journal of Clinical Oncology · 1997 · 235 citations

Medicine, Hematology, Oncology +14

A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B

RO Dillman, RB Davis, M R Green et al. · Blood · 1991 · 172 citations · Full text

Medicine, Oncology, Pharmacology +12

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia.

R B Weiss, J Freiman, Sandra L. Kweder et al. · Journal of Clinical Oncology · 1998 · 115 citations

Medicine, Hematology, Oncology +17

Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.

Daniel F. Hayes, Ricardo Mesa‐Tejada, Lawrence D. Papsidero et al. · Journal of Clinical Oncology · 1991 · 68 citations

Medicine, Oncology, Pathology +16

Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study

RA Newman, B. M. Peterson, FR Davey et al. · Blood · 1993 · 68 citations · Full text

Life Sciences, Hematology, Oncology +12